This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (313) Breast Cancer (212) Clinical Cancer Research (85) Emotional, Social, Psychological Support for Cancer (197) Participatory Cancer Care (88) Cancer Self-Management (55)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39740, first published .
Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy: Protocol for a Randomized Controlled Trial

Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy: Protocol for a Randomized Controlled Trial

Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy: Protocol for a Randomized Controlled Trial

Authors of this article:

Rebekah Wilson1, 2 Author Orcid Image ;   Dong-Woo Kang1, 2 Author Orcid Image ;   Meghan Tahbaz3 Author Orcid Image ;   Mary Norris1 Author Orcid Image ;   Hajime Uno1, 2 Author Orcid Image ;   Jennifer Ligibel2, 4 Author Orcid Image ;   Jeffrey Guenette5 Author Orcid Image ;   Cameron Christopher1 Author Orcid Image ;   Christina Dieli-Conwright1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations (7) Metrics

Rebekah Wilson   1, 2 , PhD ;   Dong-Woo Kang   1, 2 , PhD ;   Meghan Tahbaz   3 , BA ;   Mary Norris   1 , MSc ;   Hajime Uno   1, 2 , PhD ;   Jennifer Ligibel   2, 4 , MD ;   Jeffrey Guenette   5 , MD ;   Cameron Christopher   1 , MPH ;   Christina Dieli-Conwright   1, 2 , PhD

1 Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States

2 Harvard Medical School, Boston, MA, United States

3 Department of Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States

4 Division of Breast Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States

5 Division of Neuroradiology, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston, MA, United States

Corresponding Author: